Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares
FLAC
FLAC was delisted on the 22nd of November, 2022.
52 hedge funds and large institutions have $102M invested in Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares in 2022 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 9 increasing their positions, 10 reducing their positions, and 6 closing their positions.
50% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 6
40% more capital inflows, than outflows
Capital inflows: $20.8M | Capital outflows: $14.9M
4% more funds holding
Funds holding: 50 → 52 (+2)
3.73% more ownership
Funds ownership: 67.94% → 71.67% (+3.7%)
10% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Glazer Capital LLC
New York
|
+$5.47M |
| 2 |
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$3.78M |
| 3 |
RL
RPO LLC
Stamford,
Connecticut
|
+$1.94M |
| 4 |
Schonfeld Strategic Advisors
New York
|
+$1.62M |
| 5 |
PEAK6 Investments
Chicago,
Illinois
|
+$1.39M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$7.2M |
| 2 |
SFM
Spartan Fund Management
Toronto, Ontario,
Canada
|
-$2.37M |
| 3 |
Eisler Capital (UK)
London,
United Kingdom
|
-$2.04M |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
-$993K |
| 5 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
-$602K |
FLAC Hedge Fund Activity: Q3 2022 in Review
52 of the 5,831 institutional investors tracked by Wall St. Rank reported a position in Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares (FLAC) for Q3 2022, worth a combined $102M — up 6.5% from $95.9M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new FLAC positions and 6 closed out — a net gain of 3 holders — while 9 added to existing stakes and 10 trimmed.
The largest buyer was Glazer Capital LLC, adding an estimated $5.47M. The largest seller was Alyeska Investment Group, cutting an estimated $7.2M.
- 52 institutional investors held Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares (FLAC) as of Q3 2022, up from 50 in Q2 2022.
- Funds reported $102M of Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares stock for Q3 2022, up 6.5% quarter-over-quarter.
- 9 funds opened new Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares positions in Q3 2022 and 6 closed out, a net change of +3 holders.
- The largest Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares buyer in Q3 2022 was Glazer Capital LLC, an estimated $5.47M added.
- The largest Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares seller in Q3 2022 was Alyeska Investment Group, an estimated $7.2M sold.
Based on aggregated 13F filings for Q3 2022.